💡 Did you know?
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
History
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
Bayer CropScience Limited is an India-based company, which is engaged in the manufacturing, sale and distribution of insecticides, fungicides, herbicides and various other agrochemical products and corn seeds. The Company operates through the Agri Care segment. The Company’s…
Weekly engine runs — movement reflects the numbers, not analyst opinion.
A high-quality, stagnant business, trading cheap versus its own history.
Bayer CropScience is scored on the general / industrial framework. It keeps a healthy 11.9% of every rupee of sales as net profit. Those profits are backed by real cash — operating cash flow runs 1.56× reported profit. It throws off free cash worth 6.4% of its market value — a strong free-cash yield.
Over the last 3 years revenue compounded at 4%/yr and profit at -3%/yr. Book value has grown 3%/yr. Return on equity is a healthy 15.8%. In the latest quarter profit grew 98% versus the prior quarter.
At 26× earnings, the stock sits at the 8th percentile of its own 3.5-year range — the cheap end of where it has historically traded. Today's price implies ~12%/yr earnings growth for a decade. The books come through clean — a forensic grade of A, and Altman puts distress risk in the safe zone.
A plain-English restatement of the figures on this page — rules-based, for education and research context, not investment advice or a recommendation.
| Ratio | Company | Sector | Read |
|---|---|---|---|
| P/E | 24.48 | 29.13 | better |
| P/B | 6.04 | 2.52 | worse |
| EV/EBITDA | 15.68 | 16.2 | better |
| ROE | 15.8 | 4.28 | better |
| ROCE | 20.08 | 9.68 | better |
| ROA | 12.43 | 4.55 | better |
| Quick Ratio | 1.08 | 1.35 | worse |
| Peer | P/E | P/B | ROE |
|---|---|---|---|
| UPL | 20.9 | 1.4 | 5.5% |
| PI Industries | 31.7 | 3.3 | 11.8% |
| Sumitomo Chemical India | 42.0 | 7.2 | 16.0% |
4% CAGR — growing but slowly.
Revenue is outpacing profit (4% vs -3%) — costs are rising faster than the top line.
Operating margin has compressed from 19% to 15% — costs or competition are eating into profitability. Margins have declined for 2 consecutive years — watch for a structural cost problem.
ROE at 23% — the business earns well above its cost of equity.
-3% EPS CAGR — this is the rate at which each share's claim on earnings is compounding.
Operating cash flow has been positive every year — the business generates real cash, not just accounting profit. Cash conversion at 1.6× PAT — earnings are well-backed by cash; strong accrual quality. Financing outflows in consecutive years — balance-sheet discipline through debt repayment or dividends.
When operating cash keeps pace with reported profit, earnings are cash-backed; a persistent shortfall is a quality flag.
Revenue rose 68% sequentially — momentum is building. Wide quarterly swings (42% spread) — likely seasonality, lumpy orders, or project-based revenue. Run-rate stepping up — recent quarters average 14% above earlier ones.
Profit jumped 98% QoQ — check if this is operating leverage or a one-off item. Quarterly net margins are expanding (10% → 17%) — profitability per rupee of revenue is improving.
How today's P/E compares to the stock's own historical range. Dashed line = the 3.5y median.
Promoters hold 71.4% — heavily owner-operated with strong skin in the game.
Produced by a rules-based engine over licensed exchange fundamentals — every sentence above is derived from the numbers shown, no analyst or AI opinion involved. Education and research context, not investment advice. We are not SEBI-registered as an Investment Adviser or Research Analyst.